Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04296201 · ClinicalTrials.gov registry record · NA
Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology
A NA study, sponsored by Lumenis Be.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04296201 is a NA study that has completed, run by Lumenis Be. The registered enrollment target is 15 participants.
The verdict
NCT04296201, a NA study, has completed, sponsored by Lumenis Be.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
A total of at least 15 and up to 17 healthy subjects at a single site, aged 25-45 years old, who wish to receive a lifting effect and improved muscle definition, will be included in the study. The procedure will include treatments with the Legend Pro™ DMA™ technology. Photos will be obtained at pre-defined time points throughout the study.
Interventions
- DEVICE DMA treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2021-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04296201
The ClinicalTrials.gov registry entry for NCT04296201 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumenis Be, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DMA treatment is the first listed.
NCT04296201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04296201 about?
NCT04296201 is a clinical study titled "Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology". A total of at least 15 and up to 17 healthy subjects at a single site, aged 25-45 years old, who wish to receive a lifting effect and improved muscle definition, will be included in the study. The procedure will include treatments with the Legend Pro™ DMA™ technology. Photos will be obtained at pre...
What is the current status of trial NCT04296201?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-09-01. Estimated completion is 2021-02-15.
What interventions are being tested in trial NCT04296201?
The interventions under investigation include: DMA treatment (DEVICE).
Who is sponsoring clinical trial NCT04296201?
This trial is sponsored by Lumenis Be, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.